A Transport Vehicle‐enabled TREM2 agonist antibody induces putative transcription factor activation in microglia
Kathryn M. Monroe · 2025
Read A Transport Vehicle‐enabled TREM2 agonist antibody induces putative transcription factor activation in microglia by Kathryn M. Monroe (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709364.txt.
Description
Kathryn Monroe reports how an engineered antibody changes gene activity in mouse brain immune cells, in a 2025 paper. Loss of function in a receptor called TREM2 raises Alzheimer's risk, so switching it on is a candidate therapy. The antibody carries a transport vehicle that ferries it across the blood-brain barrier. Earlier work showed it pushes microglia, the brain's immune cells, into responsive states unlike those from disease itself.
Monroe isolated microglial nuclei from frozen brain tissue and mapped which parts of their DNA lay open. Treated cells showed changed openness compared with a control antibody. Computer analysis of the open regions pointed to certain regulatory factors whose binding sites appear there. The findings name candidate switches that may drive the microglia's response. That, in turn, clarifies how turning on the receptor reshapes the cells, a step toward judging the therapy's promise.
Catalog record
| CREATOR | Kathryn M. Monroe |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |